Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05035888
Other study ID # Yi Chen-2021-6
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 5, 2022
Est. completion date January 3, 2023

Study information

Verified date September 2022
Source General Hospital of Ningxia Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the potency between prophylactic norepinephrine and phenylephrine boluses for postspinal anesthesia hypotension in patients undergoing caesarean section.


Description:

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Vasopressor has been highly recommended for routine prevention and/or treatment of post-spinal anesthesia hypotension. As a potential substitute drug for phenylephrine, norepinephrine has gradually been used in parturients undergoing cesarean section. There's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. However, few studies had been indicated the ED50 (prevent postspinal hypotension in 50% of patients) and ED90 of prophylactic norepinephrine bolus and its potency compared to phenylephrine for postspinal anesthesia hypotension in patients undergoing caesarean section. The purpose of this study is to investigate the potency between prophylactic norepinephrine and phenylephrine boluses for postspinal anesthesia hypotension in patients undergoing caesarean section.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date January 3, 2023
Est. primary completion date January 3, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - 18-45 years - Primipara or multipara - Singleton pregnancy =37 weeks - American Society of Anesthesiologists physical status classification I to II - Scheduled for cesarean section under spinal anesthesia Exclusion Criteria: - Body height < 150 cm - Body weight > 100 kg or body mass index (BMI) = 40 kg/m2 - Eclampsia or chronic hypertension or baseline blood pressure =180 mmHg - Hemoglobin < 7g/dl - Fetal distress, or known fetal developmental anomaly

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Phenylephrine
An initial prophylactic bolus dose of phenylephrine (37.5µg) simultaneous with spinal anesthesia. If the patient did not respond adequately to the current dose (SBP decreased to < 80% of baseline), the dose was considered to have failed and the subsequent dose for the following patient was increased to the next higher dose level. The dose administered to subsequent patients varied by increments or decrements of 12.5 µg according to the responses of previous patients according to the up-down sequential allocation.
Norepinephrine
An initial prophylactic bolus dose of norepinephrine (3µg) simultaneous with spinal anesthesia. The dose administered to subsequent patients varied by increments or decrements of 1 µg according to the responses of previous patients according to the up-down sequential allocation.

Locations

Country Name City State
China General Hospital of Ningxia Medical University Yinchuan Ningxia

Sponsors (1)

Lead Sponsor Collaborator
General Hospital of Ningxia Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The dose that would be effective in preventing postspinal anesthesia hypotension in 50% (effective dose, ED 50) and 90% (ED90) of patients Systolic blood pressure (SBP) < 80% of the baseline 1-15 minutes after spinal anesthesia
Secondary The incidence of post-spinal anesthesia hypotension Systolic blood pressure (SBP) < 80% of the baseline 1-15 minutes after spinal anesthesia
Secondary The incidence of severe post-spinal anesthesia hypotension. Systolic blood pressure (SBP) < 60% of the baseline 1-15 minutes after spinal anesthesia
Secondary The incidence of bradycardia. Heart rate < 60 beats/min. 1-15 minutes after spinal anesthesia
Secondary The incidence of nausea and vomiting. Presence of nausea and vomiting in patients after spinal anesthesia 1-15 minutes after spinal anesthesia
Secondary The incidence of hypertension. Systolic blood pressure (SBP) >120% of the baseline. 1-15 minutes after spinal anesthesia
Secondary pH From umbilical arterial blood gases. Immediately after delivery
Secondary Partial pressure of oxygen (PO2) From umbilical arterial blood gases. Immediately after delivery
Secondary Base excess (BE) From umbilical arterial blood gases. Immediately after delivery
Secondary APGAR score A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration 1 min after delivery
Secondary APGAR score A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration 5 min after delivery
See also
  Status Clinical Trial Phase
Completed NCT04028791 - Sickle Cell Trait and Exercise, Effect of Hot Environment N/A
Completed NCT04556357 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia N/A
Completed NCT04118322 - The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy N/A
Recruiting NCT03456544 - Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
Completed NCT03723109 - Airway Management During TCI vs RSI Anesthesia Induction
Completed NCT03316417 - Study of Adverse Renal Effects of Immune Checkpoints Inhibitors
Completed NCT05712018 - Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine N/A
Not yet recruiting NCT04576663 - Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia N/A
Completed NCT03006042 - Pharmacokinetics of BPV Following Bilateral US-guided TAP Block for C-section N/A
Completed NCT03011775 - Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease Phase 4
Completed NCT04556370 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia. N/A
Completed NCT03706755 - Comparison of Two Doses of Norepinephrine in Preventing Hypotension After Spinal Anesthesia Phase 4
Completed NCT02854787 - Intravenous Bolus of Phenylephrine vs. Norepinephrine in Preventing Hypotension After Spinal Anesthesia Phase 4
Completed NCT02768168 - The Effects of Dezocine Pretreatment on Dexamethasone Induced Perineal Irritation N/A
Completed NCT04272567 - Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension N/A
Recruiting NCT05310331 - Donafenib for Recurrent Cervical Cancer Phase 2
Completed NCT05690334 - Different Crystalloid Coload Volumes on the 90% ED of Norepinephrine N/A
Completed NCT05475873 - Ondansetron for Postspinal Anesthesia Hypotension N/A
Recruiting NCT03220919 - Efficacy and Safety of Weight-Based Insulin Titration Regimen in Hospitalized Patients With Type 2 Diabetes N/A
Not yet recruiting NCT04950049 - The Effect of Dilution and Prolonged Injection Time on Dexamethasone-induced Perineal Irritation N/A